NYSEAMERICAN:INFU InfuSystem (INFU) Stock Price, News & Analysis → Top-Secret Government Project Revealed (From Porter & Company) (Ad) Free INFU Stock Alerts $6.69 -0.17 (-2.48%) (As of 06/13/2024 ET) Add Compare Share Share Today's Range$6.58▼$6.9450-Day Range N/A52-Week Range$6.25▼$11.44Volume25,868 shsAverage Volume47,212 shsMarket Capitalization$142.50 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainability Get InfuSystem alerts: Email Address InfuSystem MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.76% of Float Sold ShortDividend StrengthN/ASustainability-1.20Upright™ Environmental ScoreNews SentimentN/AInsider TradingAcquiring Shares$87,300 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.40 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for InfuSystem.Read more about InfuSystem's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.76% of the float of InfuSystem has been sold short.Short Interest Ratio / Days to CoverInfuSystem has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in InfuSystem has recently decreased by 22.22%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldInfuSystem does not currently pay a dividend.Dividend GrowthInfuSystem does not have a long track record of dividend growth. Previous Next 4.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreInfuSystem has received a 55.56% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Intravenous therapy equipment", "Medical dispensing pumps", and "Catheters" products. See details.Environmental SustainabilityThe Environmental Impact score for InfuSystem is -1.20. Previous Next 2.8 News and Social Media Coverage News SentimentInfuSystem has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.88 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for InfuSystem this week, compared to 1 article on an average week.MarketBeat Follows2 people have added InfuSystem to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InfuSystem insiders have bought more of their company's stock than they have sold. Specifically, they have bought $87,300.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders10.20% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions71.13% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InfuSystem's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of InfuSystem is -669,000.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of InfuSystem is -669,000.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInfuSystem has a P/B Ratio of 2.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad GoldenCrest MetalsBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President Biden could drastically undermine your retirement plans by 2025.Learn More Today About InfuSystem Stock (NYSEAMERICAN:INFU)InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.Read More INFU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INFU Stock News HeadlinesMay 24, 2024 | insidertrades.comInsider Buying: InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) Director Acquires 4,000 Shares of StockMay 22, 2024 | insidertrades.comInfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) CFO Barry G. Steele Purchases 3,000 SharesJune 4, 2024 | businesswire.comInfuSystem to Present at Sidoti Small Cap Conference on June 12, 2024May 20, 2024 | businesswire.comInfuSystem Announces $20 Million Stock Repurchase ProgramMay 15, 2024 | markets.businessinsider.comRange Impact Reports 1Q 2024 Financial ResultsMay 15, 2024 | uk.finance.yahoo.comQ1 2024 Sanara Medtech Inc Earnings CallMay 13, 2024 | finance.yahoo.comInfuSystem Holdings, Inc. (AMEX:INFU) Q1 2024 Earnings Call TranscriptMay 9, 2024 | investorplace.comINFU Stock Earnings: InfuSystems Holdings Misses EPS, Misses Revenue for Q1 2024May 9, 2024 | finance.yahoo.comInfuSystem Reports First Quarter 2024 Financial ResultsMay 4, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Castle Biosciences (CSTL)May 2, 2024 | businesswire.comInfuSystem to Report First Quarter 2024 Financial Results on May 9, 2024May 1, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: SurModics (SRDX) and Pfizer (PFE)April 3, 2024 | businesswire.comInfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-KApril 1, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Forian (FORA), Achieve Life Sciences (ACHV) and P3 Health Partners (PIII)March 26, 2024 | investorplace.comDouble Down: 7 Beaten-Down Growth Stocks to Buy Hand Over FistMarch 20, 2024 | money.usnews.comInfuSystem Holdings IncMarch 15, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: InfuSystem Holdings, Inc. (INFU), Aquestive Therapeutics (AQST)March 15, 2024 | finance.yahoo.comInfuSystem Holdings, Inc. (AMEX:INFU) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comQ4 2023 InfuSystem Holdings Inc Earnings CallMarch 14, 2024 | msn.comInfuSystem GAAP EPS of $0.00 in-line, revenue of $31.77M beats by $1.77MMarch 14, 2024 | finance.yahoo.comInfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023March 14, 2024 | finance.yahoo.comInfuSystems Holdings Inc (INFU) Reports Solid Growth in 2023 with Record Net Revenues and ...March 8, 2024 | businesswire.comInfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024February 29, 2024 | seekingalpha.comInfuSystem Holdings: 2024 Will Be A Year Of MonetizationFebruary 1, 2024 | markets.businessinsider.comAnalysts’ Top Healthcare Picks: EDAP TMS (EDAP), DermTech (DMTK)See More Headlines Receive INFU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today6/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSEAMERICAN:INFU Previous SymbolNYSE:INFU CUSIPN/A CIK1337013 Webir.infusystem.com Phone(124) 291-1210Fax800-455-4338Employees499Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.00 Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$870,000.00 Net Margins0.07% Pretax Margin0.93% Return on Equity0.16% Return on Assets0.08% Debt Debt-to-Equity Ratio0.57 Current Ratio1.87 Quick Ratio1.51 Sales & Book Value Annual Sales$125.79 million Price / Sales1.13 Cash Flow$0.62 per share Price / Cash Flow10.83 Book Value$2.47 per share Price / Book2.71Miscellaneous Outstanding Shares21,300,000Free Float19,123,000Market Cap$142.50 million OptionableNot Optionable Beta1.37 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Richard A. DiIorio (Age 49)CEO & Director Comp: $1.14MMs. Carrie A. Lachance B.S.N. (Age 47)M.B.A., R.N., President, COO & Director Comp: $831.31kMr. Barry G. Steele (Age 53)Executive VP & CFO Comp: $725.43kMr. Addam Chupa (Age 45)Executive VP & Chief Information Officer Mr. Jerod Funke (Age 49)Executive VP & Chief HR Officer Jeanie LatzCorporate SecretaryMore ExecutivesKey CompetitorsParagon 28NYSE:FNASI-BONENASDAQ:SIBNIradimedNASDAQ:IRMDBioventusNYSE:BVSOrthofix MedicalNASDAQ:OFIXView All CompetitorsInsiders & InstitutionsRalph F Boyd JrBought 4,000 shares on 5/23/2024Total: $28,520.00 ($7.13/share)Addam ChupaBought 1,000 shares on 5/21/2024Total: $6,670.00 ($6.67/share)Barry G SteeleBought 3,000 shares on 5/20/2024Total: $19,410.00 ($6.47/share)Paul Andrew GendronBought 5,000 shares on 5/20/2024Total: $32,700.00 ($6.54/share)AWM Investment Company Inc.Sold 100,000 shares on 5/16/2024Ownership: 8.920%View All Insider TransactionsView All Institutional Transactions INFU Stock Analysis - Frequently Asked Questions Should I buy or sell InfuSystem stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InfuSystem in the last twelve months. There are currently 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "strong buy" INFU shares. View INFU analyst ratings or view top-rated stocks. Are investors shorting InfuSystem? InfuSystem saw a decline in short interest in the month of May. As of May 31st, there was short interest totaling 142,500 shares, a decline of 22.2% from the May 15th total of 183,200 shares. Based on an average daily trading volume, of 54,200 shares, the short-interest ratio is currently 2.6 days. Currently, 0.8% of the company's shares are sold short. View InfuSystem's Short Interest. How were InfuSystem's earnings last quarter? InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) posted its quarterly earnings results on Thursday, May, 9th. The medical instruments supplier reported ($0.05) EPS for the quarter. The medical instruments supplier earned $32 million during the quarter. InfuSystem had a trailing twelve-month return on equity of 0.16% and a net margin of 0.07%. What other stocks do shareholders of InfuSystem own? Based on aggregate information from My MarketBeat watchlists, some companies that other InfuSystem investors own include Macquarie Infrastructure (MIC), Second Sight Medical Products (EYES), Otelco (OTEL), Pershing Gold (PGLC), Palatin Technologies (PTN), AgroFresh Solutions (AGFS), Advanced Micro Devices (AMD) and Digital Turbine (APPS). Who are InfuSystem's major shareholders? InfuSystem's stock is owned by a number of institutional and retail investors. Top institutional shareholders include AWM Investment Company Inc. (8.92%), Vanguard Group Inc. (5.10%), First Eagle Investment Management LLC (2.85%), Cove Street Capital LLC (1.85%) and Russell Investments Group Ltd. (1.68%). Insiders that own company stock include Addam Chupa, Barry G Steele, Carrie Lachance, Christopher R Sansone, Gregg Owen Lehman, Jeannine Sheehan, Kevin Whitman, Paul Andrew Gendron, R Rimmy Malhotra, Ralph F Boyd Jr, Richard Dilorio and Thomas Mark Ruiz. View institutional ownership trends. How do I buy shares of InfuSystem? Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:INFU) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredLike Investing in Big Tech in the Early 2000s?More than a decade after the first Bitcoin was mined, people are finally realizing something very important......Manward Press | SponsoredThe Single Biggest Breakthrough of the Decade Billionaires, Jeff Bezos, Bill Gates, Warren Buffett, and Sir Richard Branson are rallying behind this technol...Porter & Company | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InfuSystem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.